News Story - Merck HPV Vaccine Gets The FDA Nod; Hard Part To Come - News

[Guest guest]

Aasa (penas7ar@...) has sent you a news article.

(Email address has not been verified.)

------------------------------------------------------------

Personal message:

HPV vaccine may be a hard sell after all:

A.G. analyst Albert Rauch says worldwide sales could reach $3 billion.

Merck's deal calls for it to give 25% of the proceeds to third parties that

contributed to the vaccine's development. Gardasil generated nearly $10 million

in revenue in the first three weeks of its launch last quarter.

Analysts don't expect the vaccine to reach its potential for three to five

years.

" We're expecting a slower ramp- up than most vaccines, " Rauch said.

-----------------------------------------------

I wonder what adverse reactions to this vaccine might materialize in the next

few years, considering Gardasil has not been evaluated for its potential to

cause carcinogenicity or genotoxicity. See page 8 of the following link:

http://www.fda.gov/cber/label/hpvmer060806LB.pdf .

Aasa

Merck HPV Vaccine Gets The FDA Nod; Hard Part To Come - News

http://news./s/ibd/20060818/bs_ibd_ibd/2006818health

============================================================

News

http://news./